Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03931291
Brief Title: APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant

First Submitted : April 26, 2019
First Submitted that Met QC Criteria : April 26, 2019
First Posted : April 30, 2019

Last Update Submitted that Met QC Criteria : January 18, 2022
Last Update Posted : January 19, 2022